openPR Logo
Press release

Global ENT Disorder Treatment Market to Surpass US$ 10 Billion by 2025

03-30-2018 01:53 PM CET | Health & Medicine

Press release from: Medical Devices Market Report

Global ENT Disorder Treatment Market to Surpass US$ 10 Billion

ENT Disorder Treatment Market – Hear Better, Breathe Better, Live Better

ENT also known as otolaryngology is a stream of medical science that deals with disorders associated with ear, nose, and throat. Diseases related to ears, throat, and nose significantly affect the quality of life and could lead to surgeries in few cases such as chronic tonsillitis, ear infections, and severe sinusitis problems as well as cancers of the throat or larynx, and others. In order to treat these disorders, ENT treatment is required. These diseases can either be treated with the help of devices or drugs, however, surgeries are recommended to patients with severe disease cases. Surgical procedures are required in few cases such as throat cancer as recommended by otolaryngologist, however, an oncologist performs the tumor removal procedures, which is either followed by a radiation or chemotherapy, depending on the severity.

To understand Research Methodology, please click: https://www.coherentmarketinsights.com/insight/request-sample/1326

The global ENT disorder treatment market was valued at US$ 9,521.1 million in 2016 and is expected to witness a robust CAGR of 3.22% over the forecast period (2017–2025).

Increasing air and noise pollution is expected to aid in growth of ENT disorder treatment market

One of major factors leading to rise in number of ENT diseases is increasing air and noise pollution as well as bacterial concentration in the environment leading to various infections. According to the World Health Organization, 2017, around 40% of the European population is exposed to road traffic noise levels exceeding 55dB, leading to chronic hearing diseases such as loss of hearing, and earache. Moreover, air pollution can lead to throat infections as well as nasal infections leading to sinusitis and other disorders. According to the Centers of Disease Control and Prevention (CDC) 2017, around 25% of all hearing loss cases are due to noise and sound caused due to environmental pollution termed as Noise Induced Hearing Loss (NIHL). Moreover, excessive smoking can also lead to throat diseases leading to cancer. According to the American Cancer Society, 2013, around 26,000 people living in the U.S. were diagnosed with cancer of the larynx and throat due to tobacco smoking and consumption. Several other factors leading to growth of ENT disorder treatment market include high investments in R&D for development of ENT diseases treatment, especially for rhinitis; growing cases of bacterial diseases, and others. However, side effects and high cost of treatment coupled with low awareness about treatment for ENT disorders are factors expected to negatively affect growth of the market growth.

New development of antibiotics and increasing approvals of antibiotics would provide opportunities for the market growth over the forecast years. For instance, in April 2014, FDA approved Grastek (Timothy Grass Pollen Allergen Extract) for the treatment of pollen induced allergic rhinitis developed by Merck.

North America is expected to be dominant in the global ENT disorder treatment market over the forecast period. This is attributed to major presence of key players and increasing focus towards enhancing existing treatment options. For instance, in December 2017, Intersect ENT, Inc. — a U.S.-based company — received FDA approval for Sinuva (mometasone furoate) sinus implant as a treatment option for patients suffering from recurrent nasal polyps. Asia Pacific market is expected to witness a significant growth, owing to increasing awareness among people regarding availability of medical treatments for ENT disorders as well as expansion of key vendors in Asian countries by setting up new manufacturing and distribution facilities. For instance, in October 2017, GlaxoSmithKline — a major pharmaceutical player — opened Asia Headquarters in One-North Singapore.

Development of new therapies and product launches are factors expected to boost the market growth

The recent past has witnessed a number of product approvals from the U.S. Food and Drug Administration (FDA) for ENT diseases, as a result of continuous R&D, to offer effective and efficient treatment options. For instance, in December 2015, Otonomy, Inc. — a U.S.-based company — received FDA approval for commercialization of its new antibiotic OTIPRIO (ciproflaxin otic suspension) for treatment of pediatric patients with bilateral otitis media. Key players are also focusing on inorganic strategies such as merger and acquisitions for enhancement of research department as well as commercialization of products in terms of sales and marketing. For instance, in July 2017, Entellus Medical announced a definitive agreement to acquire Spirox, Inc. a privately held ENT medical technology that develops, manufactures and markets absorbable nasal implants and other medical devices.

Ask for customization: https://www.coherentmarketinsights.com/insight/request-customization/1326

Key players operating in the global ENT disorder treatment market include Sanofi, AstraZeneca, Novartis AG, Pfizer Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., GlaxoSmithKline Pharmaceuticals, Otonomy Inc., Merck & Co., Dr. Reddys Laboratories Ltd., Allergan plc, Cochlear Ltd., Sonova Holding AG, Siemens Healthcare, Starkey Laboratories Inc., William Demant Holding A/S, Widex A/S, GN ReSound A/S, Sonic Innovations Inc., Panasonic Corp., Beltone, Rexton Inc., Avada Hearing Care, Miracle-Ear Inc., MED-EL GmbH, Nuear Hearing Aids Inc., Audiosync Inc., Bernafon, American Hearing Systems Inc., Unitron Hearing Inc., and Zounds Inc.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Visit our news Website: http://www.coherentchronicle.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global ENT Disorder Treatment Market to Surpass US$ 10 Billion by 2025 here

News-ID: 999267 • Views: 395

More Releases from Medical Devices Market Report

Endometrial Ablation Market - Global Industry Insights 2025
Endometrial ablation is process that facilitates the destruction of endometrium or thin layer of the uterine wall, in context to treat abnormal heavy uterine bleeding if not controlled with any means of medication. Endometrial ablation is not recommended in women with disorders of endometrium, endometrial hyperplasia, cancer of uterus, recent pregnancy and certain infections of uterus, as per the American College of Obstetrics and Gynecology (ACOG). Depending on technique and
Blood Collection Devices Market - Global Industry Insights 2025
Blood collection devices plays a crucial role in the patient treatment. For the treatment, blood samples are collected to measure the basic metabolism components such as blood urea nitrogen, sodium, potassium, creatinine, magnesium, chloride, and also used to measure blood glucose and lipid levels. In the recent years, as technology has increased in availability and complexity, the experts in the laboratories are receiving wide range of opportunities and challenges. In
Casting and Splinting Products Market - Global Industry Insights 2025
Casts and splints are designed to protect and support injured or fractured joints and bones. They help to immobilize broken bones or dislocated joints in place, until fully healed. A cast is the treatment of choice in fractures where a minimal amount of swelling is expected, including fractures that are non-displaced as well as complicated conditions such as Paige’s, wherein a cast is placed after subsided swelling due to initial
Immunoassay Instruments Market - Global Industry Insights, Trends, and Opportuni …
Immunoassay Instruments are bioanalytical devices used to perform automated biochemical tests for the detection of various substances or specific proteins in the samples. The immunoassay instruments, also known as analyzers are used in hospitals and clinical laboratories to detect the concentration and presence of analytes in the blood, plasma and urine samples. The immunoassay tests rely on the ability of antibody binding to a specific structure of molecule present in

All 5 Releases


More Releases for ENT

United States ENT Endoscopes Market Report
In this report, the United States ENT Endoscopes market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report splits the United States market into seven regions: The West Southwest The Middle Atlantic New England The South The Midwest with sales (volume), revenue (value), market share
ENT Chairs Market – Global Industry Insights, Trends
ENT is an area of medicine dealing with treatment of human body parts namely ear, nose, and throat (ENT) and few related areas such as neck and face. The medical disorders treated by ENT physicians include chronic ear infection, sinusitis, snoring, sleep apnea, hearing loss, allergies, hay fever, swallowing disorders, nosebleeds, hoarseness, dizziness and neck cancer. Ear, nose and throat specialists or otolaryngologists have specific tools for treating patients well
ENT Chairs Market – Global Industry Insights, 2025
ENT is an area of medicine dealing with treatment of human body parts namely ear, nose, and throat (ENT) and few related areas such as neck and face. The medical disorders treated by ENT physicians include chronic ear infection, sinusitis, snoring, sleep apnea, hearing loss, allergies, hay fever, swallowing disorders, nosebleeds, hoarseness, dizziness and neck cancer. Ear, nose and throat specialists or otolaryngologists have specific tools for treating patients well
2017 ENT Devices Market Embraces Advancements
In this report, the global ENT Devices market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of ENT Devices in these regions, from 2012 to 2022 (forecast), covering North
ENT 2017_Conference_New Orleans, USA
On behalf of Allied Academies, it is our pleasure to invite you all to the “5th American Otolaryngology - ENT Surgery Conference” during November 09-10, 2017. New Orleans, Louisiana, USA. The International conference offers a focus on “Emerging Trends and Innovations in Otolaryngology-ENT”. For more details, visit us: http://ent.alliedacademies.com/ The ENT 2017 will cover the various key issues related to Head and Neck such as Head and Neck Surgery, Otolaryngology (ENT),
Jacksonville ENT Surgery welcomes new Medical Assistant
Jacksonville, Fla., Feb. 15, 2017 – Jacksonville ENT Surgery is pleased to welcome Lejla Juklo to their team as a certified medical assistant. Juklo will be responsible for taking a patient’s medical history, vital signs, preparing rooms for patient exams, assisting with allergy testing, CT scans and assisting the providers. She will be rotating between Jacksonville ENT Surgery’s five locations in Jacksonville, Jacksonville Beach and Lake City. Juklo is a